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Dynamic issues associated with infection create unprecedented demands for quality 
healthcare improvements and modifications. Researchers found extended antibiotic 
infusions to be an effective treatment option with significant clinical benefits to patients 
and astounding cost savings. This scholarly project identified the emergence of several 
clinical issues threatening to undermine the intended patient responses to extended 
antibiotic infusion therapy in one large hospital system.   
Problem:  Unrecognized infusion delays and short infusion durations created the need for 
an educational pilot initiative to improve the administration process of 
piperacillin/tazobactam on one nursing unit.   
Intervention:  Nurses on the pilot unit received instruction regarding the 
pharmacodynamics of time-dependent antibiotics and the infusion management of dead 
space volumes.  Random infusions were monitored post instruction for consistency and 
accuracy.   
Results:  Of the 73 nurses who were emailed a self-instruction module, a total of 30 
(41%) nurses submitted an attestation for completing the instruction.  Each nurse 
completing the instruction responded 100% correctly to all five post-test questions (150 
questions/150 correct).  Of the randomly observed post-instruction infusions, 17 of 29 
pumps (59%) were programmed to infuse according to the instruction.  Infusions 
programmed for 100% of the duration ordered increased from zero to 59% post 
instruction.  The difference in minimum inhibitory concentration (MIC) pre and post 
instruction demonstrated a 72% improvement in the therapeutic duration delivery of 
piperacillin/tazobactam.   
iv 
 
Conclusion:  The educational intervention, designed to redefine the beginning of the 
extended antibiotic infusion, was recommended as a sustainable solution to this practice 
problem.  
 Keywords:  extended antibiotic infusions, prolonged antibiotic infusions, 
piperacillin/tazobactam, stewardship, smart pump, dead space volume, infusion 
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Problem Recognition and Significance 
Introduction 
 Healthcare continues to be transformed by medical advances and technology.  
Continuous research and advancements challenge healthcare professionals to keep up 
with ongoing changes.  Dynamic issues associated with acuity and comorbidities, such as 
infection, create unprecedented demands for quality improvements and modifications.  
Prior to 2010, researchers found extended antibiotic infusions to be an effective treatment 
option with major cost savings (Droege, Van Fleet, & Mueller, 2016; Falagas, Tansarli, 
Ikawa, & Vardakas, 2013; Yost & Cappelletty, 2011). As global applications of extended 
antibiotic infusions spread rapidly to reduce healthcare costs, researchers realized 
significant clinical benefits and positive patient outcomes (Droege et al., 2016; Falagas et 
al., 2013; Heinrich et al., 2011; Maddox, DeBoer, & Hammerquist, 2014).  Significant 
reductions in mortality rates and lengths of stay (LOS) began frequenting the literature as 
a direct result of extended antibiotic infusion therapy (Droege et al., 2016; Falagas et al., 
2013; Heinrich et al., 2011; Lee, Liou, Yee, Quan, & Neldner, 2012; Maddox et al., 2014; 
Yost & Cappelletty, 2011; Yusuf, Spapen, & Pierard, 2014). 
Clinical Scenario 
Mr. Johnson was admitted to the hospital for diverticulitis and underwent a 
sigmoid colectomy for repair of a micro-perforation of the sigmoid colon.  Routine 
postoperative management included the administration of an extended antibiotic infusion 
of piperacillin/tazobactam (Zosyn®) 3.375 grams intravenously in 50 milliliters (mL) of 





nurse assigned to care for Mr. Johnson on his first postoperative morning entered his 
room at 0700 and found his 0400 dose of Zosyn still infusing at the appropriate rate of 
12.5 mL hourly.  At 0800, the nurse completed the four-hour infusion as indicated on the 
electronic medication administration record (MAR), disconnected the tubing from the 
patient, and flushed the peripheral intravenous (IV) access with NS in accordance with 
protocol.  The night nurse documented the administration of the medication at the time 
the Zosyn was hung according to the secondary intravenous infusion policy and the day 
nurse completed the extended infusion.   
This scenario routinely occurs in the selected healthcare organization with 
supporting documentation that extended antibiotic infusion administration is flawless.  
Further investigation, however, reveals several variables with the potential to 
significantly undermine intended patient responses to this pharmacologic therapy.  
Variables include:  
• primary and secondary infusion tubing preparation policies, 
• total infusion tubing volumetric capacity (known as dead space; see 
Figure 1), 
• primary line NS flush amounts and rates post-infusion to clear the line of 
drug,  
• MAR documentation of the infusion start time with an automated stop 
time documentation exactly four hours following initiation, 
• individual nursing judgment regarding completion of infusion begun by 





This scholarly project identifies the emergence of several clinical issues threatening to 
undermine the intended patient responses to extended antibiotic infusion therapy in one 
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Concepts and Definitions of Terms 
Pharmacodynamics of Piperacillin/tazobactam 
Piperacillin/tazobactam is a β-Lactam classified antibiotic with time-dependent, 
rather than concentration-dependent, pharmacodynamics.  Time-dependent antibiotics 
have shorter half-lives and can only achieve optimal bacterial killing while being 
bacteria-bound for a specific duration of time (Deglin & Vallerand, 2015; Droege et al., 
2016).  Peak concentrations of time-dependent antibiotics have limited effect on bacterial 
killing. It is the duration of bacterial exposure to the time-dependent antibiotic that 
ultimately determines the extent of bacterial destruction.  Minimum inhibitory 
concentration (MIC) refers to the least amount of antibiotic needed to kill at least 90% of 
a bacterial pathogen (Droege et al., 2016; Falagas et al., 2013).  An antibiotic’s MIC must 
be exceeded for the intended duration to sustain bacterial killing.  MICs vary between 
40% and 70% of dosing intervals for different antibiotics (Droege et al., 2016).   
Physicians ordering a four-hour piperacillin/tazobactam infusion every eight 
hours are targeting 50% of the dosing interval to exceed the MIC.  Four-hour 
piperacillin/tazobactam infusions every eight hours have been found to have the same 
clinical benefits for patients as continuous piperacillin/tazobactam infusions (Falagas et 
al., 2013).  Antibiotic infusions administered too quickly result in shortened durations, 
thus minimizing bacterial killing. In addition to achieving optimal bacterial killing, a 
pathogen’s MIC has been associated with the potential for inhibiting multi drug-resistant 








Extended antibiotic infusion therapy has been studied heavily this century in 
response to the escalation of antibiotic resistant bacterial strains and MDROs (Falagas et 
al., 2013; Fan et al., 2017).  Last year, the Centers for Disease Control and Prevention 
(CDC) reported over two million antibiotic resistant cases resulted in approximately 
23,000 deaths in the United States (CDC, 2017).  MDROs are the result of inconsistent 
and ineffective antibiotic usage (CDC, 2017).  Antibiotic stewardship refers to the 
deliberately organized inter-professional strategies to ensure optimal antibiotic use in 
combating infection (American Nurses Association [ANA]/CDC, 2017; CDC, 2017).  
Intravascular exposure of the pathogen to the antibiotic for an extended duration is 
intended to facilitate extended bacterial killing while suppressing the development of 
resistant bacterial mutations.  Nurses play an integral role in the stewardship against 
MDROs in various healthcare settings (ANA/CDC, 2017; Droege et al, 2016; Manning, 
Pfeiffer, & Larson, 2016; Monsees, Goldman, & Popejoy, 2017; Morgan, 2017; Olans, 
Olans, & DeMaria, 2016).  It is important for nurses to develop and maintain a current 
understanding of the pharmacodynamics and pharmacokinetics behind the best practice 
evidence supporting extended antibiotic infusions (ANA/CDC, 2017; Droege et al, 2016; 
Manning et al., 2016; Monsees et al., 2017; Morgan, 2017).  The ANA and CDC 
collaborated to emphasize the need for nursing involvement in antibiotic stewardship to 
improve antibiotic use in healthcare settings (ANA/CDC, 2017).  The CDC (2017) 
developed four core actions, including stewardship, to guide professionals in combating 





medication management teams in hospitals as of January 1, 2017, specifically requiring 
antimicrobial stewardship action in controlling MDROs.     
Dead Space 
 Dead space refers to the volumetric capacity of the intravenous infusion pathway 
a solution travels from exiting its original container until reaching the patient’s 
intravascular space (Lam, Bhowmick, Gross, Vanschooneveld, & Weinstein, 2013).  
Dead space for the extended antibiotic infusion varies depending on the volumetric 
capacities of several infusion pathway setup options.  Setups vary according to patient 
condition and therapy needs, available supplies, and individual nursing judgment.  The 
basic setup (see Figure 1) dead space volume ranges from 21 to 28 mL, including 
possible extensions and catheters.    
 The amount of dead space is most significant when the infusion volume is small 
(less than 100 mL) and rates are slow (less than 20 mL/hour) (Alexander & Zomp, 2015).  
Dead space must be completely displaced by piperacillin/tazobactam before the 
medication arrives at the patient’s intravascular space.  Without this displacement, the 
slow rate of the extended piperacillin/tazobactam infusion (12.5 mL/hour) creates an 
infusion delay of approximately two hours.  Likewise, when piperacillin/tazobactam 
completely exits its original container, the dead space remains filled with the medication.  
This dead space must be flushed by the primary solution at the same rate the medication 
is ordered because the medication is continuing to infuse (Callahan, 2015). 
Backpriming 
 Backpriming refers to the retrograde filling of the secondary intravenous infusion 





medication from the previous infusion with primary solution into the used medication bag 
which is then discarded.  Medications, such as piperacillin/tazobactam, must be stored in 
the refrigerator or reconstituted just prior to infusion to maintain optimal 
pharmacodynamic effectiveness.  Residual medication in the secondary dead space 
following an infusion has been at room temperature for several hours and is discarded 
through the backpriming process.   
 Infusion management requires nurses to decide whether or not to backprime prior 
to each secondary medication infusion.  Backpriming to discard residual medication 
versus infusing the residual medication in the secondary infusion pathway is currently left 
to nursing judgment.  The current nursing practice is generally to backprime for all 
secondary medication infusions and dedicate each tubing to its own medication for reuse 
for up to four days.   
Background 
Extended Antibiotic Infusions 
The selected practice organization is a large private, nonprofit health care system 
in North Carolina that received Magnet recognition by the American Nurses 
Credentialing Center in 2015.  Extended antibiotic infusions of piperacillin/tazobactam 
were added to the pharmacotherapy options at the selected organization in 2010 using 
smart pump infusion technology (S. Holt, lead pharmacist overseeing extended antibiotic 
infusions in the selected organization, personal communication, September 15, 2017).  
Piperacillin/tazobactam infusions formerly administered over 30 minutes at intervals of 
six hours began being administered over four hours at intervals of eight hours.  The 





Both intermittent infusions currently remain in use as pharmacotherapy options in the 
selected organization.   
Practice Problem  
The administration of extended antibiotic infusions in this organization has 
encountered two nursing practice problems.  These problems were initially identified 
through empirical data discovered over an extended period of direct involvement in the 
clinical setting.  The first issue surrounds the inaccuracies of the nursing administration 
process of extended antibiotic infusions.  The second issue involves the organizational 
system failure to recognize medication administration mishandling with potentially 




















Organizational Gap Analysis 
Best-practice evidence regarding extended antibiotic infusions is relatively recent 
in nursing literature and can be associated with a characteristic knowledge to action 
healthcare practice gap, as in this selected organization.  This nursing practice gap is 
characteristic of the assimilation of new evidence and its integration into practice (Field, 
Booth, Ilott, & Gerrish, 2014).  Based on nursing interviews summarized in Table 1, 
patients are currently receiving an uncertain amount of medication at a significantly 




Table 1.   
 
Causes and Effects of Current Extended Infusion Administration  
 
Administration action Impact Problem Inaccuracies 
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 Following the extended infusion period, flushing procedures used to clear residual 
drug volume in the tubing vary among nurses in the selected organization as outlined in 
Table 1.  According to personal communication, nurses often speed up the volume to 
infuse rapidly, which negates the time-dependent pharmacodynamics needed for effective 
therapy.  Current documentation validates that the nursing administration of extended 
antibiotic infusion is consistent and accurate.  The assumption throughout the 
organization, based on this documentation, is that piperacillin/tazobactam is being 
administered consistently and accurately.   
As illustrated in Table 1, nurses are administering inconsistent dosage durations.  
Nurses are administering inaccurate dosage durations. Nurses are, unintentionally, 
documenting inaccurate infusion administration. The “right dose”, “right time”, and 
“right documentation” professional standards for nurses are jeopardized by the current 
practice.  In addition, the practice problem continues to be unrecognized and uncorrected.   
Problem Statement 
Integration of best-practice pharmacotherapy of extended piperacillin/tazobactam 
infusions has evolved inconsistently in the selected organization.  The practice problems 
in the selected organization are:  (1) the inaccurate nursing administration of extended 
antibiotic infusions and (2) the organizational system failure to recognize medication 
administration mishandling with potentially serious clinical and financial threats.   
Scope of the Practice Problem 
Current Practice 
Extended piperacillin/tazobactam infusions are a frequently utilized 





gram negative infections.  Shannon Holt, lead pharmacist overseeing extended antibiotic 
infusions in the selected organization, reported piperacillin/tazobactam is the primary 
pharmacotherapy for gram negative infection (S. Holt, personal communication, 
September 15, 2017).  Holt also reported no increases in either gram negative infection 
rates or drug-resistant strains since the pharmacy-led implementation of extended 
piperacillin/tazobactam infusions in 2010.  Since the implementation, however, 
significant benefits of mortality and LOS reductions have predominated the literature.  
Mortality and LOS have become the primary indicators for extended antibiotic infusion 
therapy (Droege et al., 2016; Falagas et al., 2013; Heinrich et al., 2011; Maddox et al., 
2014).   
Piperacillin/tazobactam administered in extended dosages in the practice 
organization occurred multiple times daily on one clinical unit during direct observation 
periods.  Associated practice problems can be attributed to knowledge deficits regarding 
the time-dependency of piperacillin/tazobactam and infusion dead space volumes.  
Nurses administering piperacillin/tazobactam infusions have limited policy guidance to 
manage infusion dead space volumes and their effects on infusion durations.  Knowledge 
deficits and policy confusion regarding infusion volumes have resulted in loss of 
approximately 50% of time-dependent infusion therapy with each dose (see Figure 2).  
The ANA and CDC White Paper identified antibiotic-related practice problems as a 
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Figure 2.  Eight-hour Medication Frequency Timeline 
 
Clinical Issues 
• Current infusion policy allows varied interpretations of extended infusions. 
• Nurses beginning infusion at the bag rather than the intravascular space due to 
dead space volume. 
• Reliance of nurses on smart-pump technology capabilities. 
• Absence of infusion volume capacity on infusion supplies packaging to inform 





• EPIC documentation of infusions beginning at false times. 
• Potential variance of actual dosages patients receive with replacement of dead 
space volume following infusion. 
• Assumptions of contributors to the infusion process are that nursing management 
























Review of Literature 
Best-Practice Evidence 
Antibiotic therapy has historically been guided by bacterial susceptibility to a 
certain antibiotic.  MDROs to the most commonly used antibiotics has resulted in the 
emergence of alternative dosing strategies such as the extended antibiotic infusion 
(Droege et al., 2016; Falagas et al., 2013).  Certain antibiotics, such as 
piperacillin/tazobactam, have proven in vitro to be most bactericidal when infused over 
an extended period, making them time-dependent antibiotics (Droege et al., 2016; 
Falagas et al., 2013; Fan et al., 2017; Lee et al., 2012).  Minimal drug concentrations are 
needed to inhibit bacterial growth, but concentrations must remain constant for an 
extended duration to effectively destroy bacteria.  Receiving the entire dose too quickly 
interrupts bacterial exposure to the minimal inhibitory concentration (MIC) required to 
prevent bacterial growth (Droege et al., 2016; Falagas et al., 2013; Fan et al., 2017).  
Therefore, although a bacterial pathogen may be susceptible to an antibiotic and the 
entire dose is administered, bacteria are given the opportunity to multiply between 
antibiotic doses.  In a study of 5,000 patients with hospital associated pneumonia, Kim, 
Kuti, and Nicolau (2009) found that three-hour piperacillin/tazobactam infusions were 
not as effective as other beta-lactams; but all were more effective than 30-minute 
duration infusions.  Administering time-dependent antibiotics too quickly has been 
associated with longer hospital stays and with greater mortality (Falagas et al., 2013; 





In a cohort study of 194 patients with pseudomonas infections, Lodise, 
Lomaestro, and Drusano (2007) were the first to associate significant mortality and 
length of stay benefits with extended piperacillin/tazobactam infusions.  Falagas et al. 
(2013) shared a meta-analysis reviewing 14 studies of over 1,200 patients and their 
findings relating extended antibiotic infusions to clinical outcomes.  
Piperacillin/tazobactam effectiveness was consistently enhanced with extended infusion 
durations. Significantly decreased mortality rates and LOS were demonstrated. These 
findings continued to be corroborated by multiple researchers as extended infusions were 
integrated into global healthcare settings (Lee et al., 2012; Maddox et al., 2014; Schmees 
et al., 2016; Yost & Cappelletty, 2011; Yusuf et al., 2014). 
Once piperacillin/tazobactam has been ordered as an extended infusion, it is 
critical that the infusion time begins when the antibiotic begins infusing into the patient’s 
intravascular space.  It is just as critical that the infusion continues slowly for the entire 
four-hour duration period. (Alexander & Zomp, 2015; Stanford Health Care, 2015).  
Alexander and Zomp (2015) reported up to 60% of the piperacillin/tazobactam dose can 
be lost to residual dead space volume.  
Administration Evidence 
 A literature review revealed the emergence of both extended antibiotic infusion 
therapy and smart pump technology throughout many healthcare settings at 
approximately the same time, between 2010 and 2015.  Other simultaneous rollouts, such 
as electronic patient record (EPR) enhancements, also emerged for many organizations 
within the same timeframe, as was the case at the selected organization.  Smart pump 





than70% as of January 2018 (Pedersen & Gumpper, 2008; Institute for Safe Medication 
Practices [ISMP], 2018).   
 Smart pump technology advanced the intravenous infusion capability from 
counting drops to pre-programmed infusion libraries with safeguards against much of the 
human error associated with medication administration (Ohashi, Dalleur, Dykes, & Bates, 
2014; ISMP, 2009; Reston, 2013).  Potential solutions to the identified practice problems 
must involve implementation and evaluation to optimize the use of best technology 
practices.  System inefficiencies associated with utilization of new technologies need 
quality improvement support that will enhance informatic growth and development 
(Ohashi et al., 2014; Trbovich, Cafazzo, & Easty, 2013).  
Infusion delivery delay is not widely covered in the literature, but it has been 
recognized as a common cognitive task deficiency among nurses (Yui Tsang, 2015).  Yui 
Tsang (2015), a pharmacist student, developed and implemented an interactive education 
simulation for identifying and teaching critical care nurses about infusion volume 
management.  Heinrich et al. (2011) implemented a hospital-wide extended piperacillin-
tazobactam infusion guideline in total replacement of the 30 minute option in an Illinois 
medical center in 2008 with positive results.  Researchers felt the single extended 
infusion option promoted consistency of administration surrounding the protocol change 
and therefore, enhanced reliability of results.   Trbovich, Pinkney, Cafazzo, and Easty 
(2010) examined nurse utilization of smart pump technology in relation to medication 
administration errors.  Researcher recommendations cautioned against complacency, 





mitigated many nursing infusion errors, other potential errors regarding pump 
programming during each infusion took their place (Trbovich et al., 2010).   
Lam et al. (2013) found that as much as 60% of the piperacillin/tazobactam 50 
mL dose has been lost to residual tubing volumes.  In studies of over 800 nurses, the 
ISMP (2018) found the most common type of smart pump errors were associated with 
secondary infusions. The reported errors demonstrated nurse confusion about secondary 
infusion doses and rates (ISMP, 2018). 
Trbovich et al. (2013) evaluated the optimal use of smart pump technology 
safeguards in 29 hospitals in Ontario.  These researchers identified that underutilization 
of potential safety features was common.  It was concluded that accuracy of the 
medication process required collaborative monitoring of smart pump usage due to 
unpredictable and complex implementation variables (Trbovich et al., 2013). Kirkbride 
and Vermace (2011) also cautioned nurse managers against the unintentional 
consequences of protective technology.  Maintenance of an accurate awareness of 
administration practices during extended antibiotic infusions throughout the organization 
will be key to success.   
Extended piperacillin/tazobactam infusions are most commonly selected to target 
susceptible pathogens such as fluoroquinolone-resistant Pseudomonas aeruginosa, 
Klebsiella pneumoniae, Escherichia coli, or carbapenem-resistant Enterobacteriaceae 
(CRE) (Droege et al., 2016).  Extended piperacillin-tazobactam infusions have yielded 
benefits of significantly reduced lengths of hospital stays and mortality rates for patients 





al., 2007; Maddox et al., 2014; Schmees et al., 2016; Yost & Cappelletti, 2011; Yusuf et 
al., 2014).   
Literature Summary 
A Literature Review Matrix outlines major details (see Appendix A). Overall, the 
evolution of evidence surrounding extended antibiotic infusion therapy demonstrates a 
transition from economical healthcare infusion benefits to clinical outcome benefits for 
patients experiencing infections.  Cost benefit, the original incentive for extended 
infusion therapy, is now secondary to significant mortality and length of stay reductions.   
Consistently competent administration of extended antibiotic infusions is 
fundamental to the achievement of successful patient outcomes the literature 
demonstrates.  Direct observation and personal communication with frontline nursing 
staff and policy-makers corroborate knowledge deficits regarding best-practice 
pharmacotherapy.  Compliance with best-practice evidence is critical to the achievement 
of similar clinical benefits for patients.  Unaddressed infusion errors during time-
dependent infusion therapy directly impact the success of clinical patient outcomes. 
Current extended infusion issues at the selected organization warrant further investigation 













Swanson’s Theory of Caring 
 Kristen Swanson’s (1993) Theory of Caring provides the theoretical framework 
for this practice project to enhance extended antibiotic infusion administration accuracy 
and efficient dose delivery for clients experiencing infections. “Nursing is informed 
caring for the well-being of others” (Swanson, 1993, p. 352). Swanson’s (1993) 
explanatory middle-range nursing theory defines “others” as individuals or groups, or 
issues that jeopardize well-being. The theory of caring outlines specific caring processes 
within the context of four phenomena common to nursing practice: persons or clients, 
health and well-being, environments, and nursing (Swanson, 1993).  These phenomena 
are common to nursing practice, but not exclusive to nursing practice (Swanson, 1993).  
The unaddressed infusion issues during administration of extended antibiotic therapy in 
the selected organization constitute a nursing practice issue that influences client well-
being.    
 The five caring processes are hierarchically structured beginning with 
“maintaining belief”, the foundational values and beliefs guiding nurses to assist others 
through their specific situations (Swanson, 1993).  This basic underlying foundation of 
beliefs inherent to nursing, through the actions of each nurse, initiates the relationship 
between the nurse and others toward some future outcome (Swanson, 1993).  Nurses 
accompany others through their experiences or situations to provide therapeutic 
assistance (Swanson, 1991).  The theory of caring identifies clinical nursing knowledge 





nurses know and understand regarding specific client data determines the care that nurses 
will tailor to be most therapeutic (Field et al., 2014; Swanson, 1993).  Holistic awareness 
and understanding of individual patient influences and needs guide nursing judgment and 
caring actions.  Swanson further elaborates that knowing promotes scholarly nursing 
practice applications and translations (Swanson, 1993).   
 The remaining three caring processes, “being with, doing for, and enabling” 
(Swanson, 1993, p. 355), directly support the effectiveness of nursing care in promoting 
client well-being.  Responsibility and accountability of nurses to others, including 
oneself, impacts individual perceptions of dignity and worth (Swanson, 1991; Swanson, 
1993).  Recipients of nursing care based on caring theory perceive protection and security 
from competent nursing skillsets (Swanson, 1991; Swanson, 1993).  Recipients of 
nursing care (whether clients, issues, or nurses themselves) progress through personal 
experiences toward an intended result (Swanson, 1993).   
 Swanson’s structured caring processes serve as the ideal organizational 
framework for planning and implementing a policy revision and quality improvement 
initiative to achieve optimal pharmacotherapy for clients (see Figure 3). The theory of 
caring provides praxis to guide all nursing relationships; those with clients, other nurses, 
other disciplines, and with oneself (Butts & Rich, 2015; Swanson, 1993).  Because these 
dynamic inter-relationships continuously influence the implementation process, they 
require ongoing assessment and management (Field et al., 2014).  Sustainable knowledge 
translation can be expected to withstand barriers to the change process through the use of 
implementation science strategies (Field et al., 2014). Implementing change within an 





Maintaining Belief Knowing 
• Being with 
• Doing for 
• Enabling 
to translate knowledge of best-practice among nurses with the intention of enhancing 








    
           















Figure 3.  Conceptual/Theoretical/Empirical (CTE) Diagram Based on Swanson’s       
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Project Mission, Goals, and Objectives 
Mission Statement 
 The purpose of this scholarly project was to improve extended antibiotic 
infusion administration of piperacillin/tazobactam therapy by teaching best practice 
strategies for consistent and compliant dose delivery needed by patients experiencing 
infections. 
Goals 
The anticipated goals for this scholarly project are: 
• Recognition and application of best-practice pharmacotherapy guiding 
extended antibiotic infusion administration  
• Recommendations for a system-wide self-instruction module for nurses  
• Recommendations for a revision to the extended infusion administration 
policy.  
Objectives 
The objectives of this scholarly project are:  
• Attestation to completion of a self-instruction module redefining extended 
antibiotic infusion administration by 100% of unit nurses       
• Summative validation of understanding regarding the nursing administration 






• Self-reported increase in understanding of the nursing administration of time-
dependent antibiotics by 100% of responding unit nurses upon completion of 
the self-instruction module  
• Consistent and accurate delivery of four-hour intravascular antibiotic exposure 
by 100% of unit nurses upon completion of the self-instruction module as 
























Site and Population 
 The selected unit for implementation of this pilot project was a 41-bed 
cardiovascular surgical intermediate care unit with approximately 80 staff nurses.  
Employment on the unit ranges from one to 35 years.  The majority of nurses have a 
Bachelor of Science in Nursing (BSN) level of education and many have achieved 
national medical-surgical certifications.   
 
Table 2 
Project Team Members 
Team Members Reasons for Selection 
Kelly Thompson-Brazill  Selected Practice Partner; DNP with respected clinical 
expertise and organizational network 
 
 Megan Swink, Morning 
unit supervisor and 
tenured staff nurse 
Selected Committee Member; knowledgeable of frontline 
staff practices on direct observation unit; respected, 
energetic, and proactive with clinical expertise and 
organizational network  
 
Sandra VanScoy, Nurse 
manager and tenure on 
observation unit 
  
Thirty-two years of tenure on direct observation unit; 
respected for availability, support, and expertise  
Shannon Holt, Pharmacist Responsible for management of antibiotic dosing in 
collaboration with Dr. Ingram, Infectious Disease 
Specialist; aggregates all data regarding extended 
antibiotic infusions 
 
Dr. Chris Ingram Infectious Disease Specialist 
 








The selected organization consistently demonstrates numerous strengths, 
especially after receiving Magnet Recognition status.  An organizational culture of 
striving for excellence in maintaining competitive quality health care outcomes for 
patients throughout the region is communicated within the hospital system as well as 
through community outreach and support.  Organizational growth and development 
demonstrate the successful mission of improving health care provision through quality 
and compassion.  Patients and families are positioned at the top of the hierarchal pyramid.  
Specific achievements validating this structure are displayed on each unit.  Employees 
actively participate in decision-making through shared governance and committee 
integration of quality improvements.  
Barriers 
Three identified barriers to integration of best infusion practices contribute to the 
inaccurate administration of piperacillin/tazobactam extended infusions in the selected 
organization.  The first barrier to overcome in implementing a solution is the knowledge 
deficit of the nursing staff associated with dead space volumes as well as the time-
dependency dynamic of piperacillin/tazobactam. Training regarding extended antibiotic 
therapy was provided to nurses at the selected organization in 2010, but frontline staff 
nurses were taught there were no advantages to extended infusions beyond cost savings.  
Subsequent evidence discovered since then identified cost savings is a secondary benefit 
of the extended piperacillin/tazobactam infusions (Heinrich et al., 2011; Maddox et al., 
2014; Droege et al., 2016).  The primary advantage to extended therapy has become its 





organization and nursing practice (Buyle et al., 2013; Falagas et al., 2013; Yusuf et al., 
2014).  Education regarding time-dependency in antibiotic administration to nurses at the 
selected organization is critical to the implementation of accurate extended antibiotic 
infusions.  Heinrich et al. (2011) demonstrated successful implementation of new 
guidelines in a structured educational training session for all involved professionals in a 
500-bed Chicago hospital.   
A second barrier to accurate extended antibiotic infusions is the absence of tubing 
volume capacity information for use by the frontline nursing staff when programming the 
infusions.  Knowledge of the volume capacity of the infusion tubing is essential to 
accurately determining infusion beginning and end points (Alexander & Zomp, 2015; 
Lam et al., 2013).  Failure to include this volume in the current infusion setup has 
resulted in a significant delivery delay in the selected organization.  With current nursing 
practice, the antibiotic does not reach the patient until the third hour of the intended four-
hour infusion.   
 The project manager discovered a third barrier to correcting the practice problem, 
more fragmentation throughout this organization than originally recognized.  The 
selected organization is large and the dynamics of problem-solving are complicated by 
the ongoing daily challenges and complexities of managing multiple campuses.  
Communication is unexpectedly difficult given the quantity of responsible stakeholders 
and the magnitude of the practice problem.  The magnitude of this practice problem adds 
an overwhelming element for stakeholders anticipating an equally complex solution.  The 
planning period needed to develop the redefinition pilot project was extended by the 





results phases, this project manager more effectively managed the intra-organizational 
division of responsibilities to streamline efforts and outputs.  
SWOT Analysis 
Strengths, weaknesses, opportunities, and threats (SWOT) analysis of the 
practices, policies, and opportunities in the selected organization revealed a gap between 
actual and intended practice procedures as illustrated in Table 3.  Internal and external 
strengths of the selected organization clearly exceed the internal and external weaknesses 
(see Table 3).  The foundational climate of the selected organization is perceived as 
professional and valuing quality care both internally and throughout the community.  
Acknowledgement of the practice problem with various stakeholders has elicited 
concerned responses and participatory implementation toward a policy update as well as 



















 Positive Negative 
Internal • Culture of striving for 
excellence in maintaining 
competitive quality health care 
outcomes for patients 
throughout the region 
• Patients and families are 
positioned at the top of the 
hierarchal pyramid   
• Specific achievements 
validating this structure are 
displayed on each unit   
• Employees involved in 
decision-making through shared 
governance and committee 
integration of quality 
improvements 
• Well-educated and skilled 
frontline nursing staff 
• Collaboration between 
pharmacy and physician 
professionals with nurses 
mutually respected throughout 
this organizational system 
culture 
• Adequate physical and fiscal 
resources 
 
• Miscommunication of 
information in rollout 
• Absence of tubing volume 
capacity information for use by 
the frontline nursing staff when 
programming the infusions 
• Policy for secondary intravenous 
infusions allows variability in the 
administration 
• Ineffective ongoing monitoring of 
extended infusions 
• Persistent nosocomial pathogens 
 
External • Community outreach and 
support 
• Organizational system growth 
and development 
• Respected reputation nationally 
• Magnet recognition  
• Successful mission of 
improving health care provision 
through quality and compassion 
 
• Increasing multi-drug resistant 










The educational intervention translated best practice evidence for the nursing staff 
on the pilot unit to relocate the intended beginning point of extended 
piperacillin/tazobactam infusions.  Clarification of the time-dependent 
pharmacodynamics emphasized the importance of beginning the infusion as the 
medication enters the patient’s bloodstream, instead of the medication’s exit from the 
medication container.  Nurses were instructed to follow a recommended administration 
process similar to the current practice with one major addition, a 25 mL manual 
secondary bolus using the smart pump to displace the dead space volume in the infusion 
tubing currently creating the infusion delay.  This process clears the secondary and 
primary dead space volume of saline between the medication container and the patient’s 
bloodstream; thus, relocating the beginning of the infusion to the patient’s bloodstream as 
the physician orders intended.  This process is compatible with either continuous 
infusions of intravenous fluids or saline locked devices.   
Intervention and Measurements 
A self-instruction module (see Appendix B) and demonstration video was emailed 
to each full- and part-time unit staff nurse (80 total nurses) by their unit management 
team.  Completion of the self-instruction module was mandated within a two-week 
period.  A post-instructional summative evaluation of five multiple choice questions 
(included in Appendix B) and a signed attestation of understanding of the information 
presented (included in Appendix B) was submitted to the unit supervisor by the end of 





evaluations and analyzed data using descriptive statistics.  Evaluation results were 
confidential.   
Post-instructional application of information was randomly observed and 
evaluated by the project manager for consistency and accuracy for a four-week period 
using a checklist based on the new extended antibiotic infusion policy. An average of 
25% of patients on the 41-bed unit were receiving this extended infusion and 11 nurses 
were staffing each day.  Both day and night shift nurses monitored between 0600 and 
1500 until at least half of the unit nurses were assessed for compliance with the new 
procedure.  Monitoring included direct observation and personal staff interviews. The 
nursing administration of infusions was randomly observed in patient rooms during the 
monitoring phase without any recording of patient or nurse information whatsoever.  For 
each randomly selected infusion, information about how the nurse was administering the 
medication was easily reviewed using the pump keypad to establish whether the 
instruction module was understood and followed.  This was an additional opportunity for 
individual remediation to be offered by the project manager as needed. The only nurse 
information needed during the monitoring phase was to check off nurses’ names that 
were observed, so they were only observed once.   
 The final outcome measure was a staff survey (see Appendix C) about the 
instruction module and staff nurse perceptions of the redefinition application.  An online 
Survey Monkey link was emailed to all nurses with an explanation and instructions (see 
Appendix C).  The project manager analyzed data using descriptive statistics and collated 





 An overall summary of results was to be shared with associated physician, 
nursing, and pharmacy representatives throughout the project site via personal 
communication, PowerPoint presentation, or email.   Ultimately, pilot project results 
were to be presented to the Nursing Practice Council, during the May 2018 meeting, 
with recommendations to facilitate system-wide practice improvements.   
Cost Analysis/Budget 
 Multiple researchers have reported reductions in mortality and LOS with the 
implementation of extended antibiotic infusions (Heinrich et al., 2011; Falagas et al., 
2013; Maddox et al., 2014; Yusuf et al., 2014).  Extended infusions have been widely 
documented as beneficial due to enhanced exposure of bacteria to antibiotic therapy with 
a cost-effective bonus of using less medication (Droege et al., 2016).  Fiscal and physical 
resources necessary for this practice implementation project would be limited to time 
expenditures; equipment and supplies are already present due to current infusion 
practices.  Time would be needed for a system needs assessment, data analysis of current 
practices, education of nurses about best infusion evidence, policy development and 
implementation, evaluation of updated practice application through direct observation, 
and quality improvement process enhancement to sustain quality practice and optimal 
care outcomes.  Costs associated with LOS, clinical outcomes, and mortality are 
considerable, multifaceted, and remain beyond the scope of this practice improvement 












Problem Recognition  June 2017 
Preliminary Literature Review of Problem July 2017 
Needs Assessment  July 2017 
Expanded Literature Review for Best Practice July 2017 
Organizational Assessment  July 2017 
Development of Goals and Outcome Objectives August 2017 
Development of Mission Statement August 2017 
 
Fall 2017 
Complete CITI Research Training September 2017 
Theoretical Underpinnings September 2017  
Work Planning October 2017 
Evaluation Planning November 2017 
Continuing Practice Immersion Experience November 2017 
Register for Spring 2018 December 2017 
Complete and Submit Project Proposal December 2017 
 
Spring 2018 
Apply for GWU Summer Graduation January 2018 
Application for Hospital IRB Exempt Status  January 2018 
Application for GWU IRB Exempt Status January 2018 
Implementation February 2018 
Implementation Monitoring March 2018 
Data Analysis and Aggregation April 2018 
Implementation and Practice Immersion Closure  May 2018 
Recommendations to Nursing Practice Council May 2018 
Evaluation May 2018 
 
Summer 2018 
Written Dissemination/ June 2018 
Oral Dissemination July 2018 
Electronic Dissemination/Manuscript Preparation July 2018 
ProQuest Submission July 2018 










 This quality improvement project piloted an educational initiative to inform 
nursing staff on one nursing unit of best practice evidence affecting extended antibiotic 
infusion management.  Two project initiatives were implemented:   
(1)  Nursing Educational Initiative 
• Self-instruction module (see Appendix B) translated evidence about time 
dependent antibiotic infusions for improved administration 
• Demonstration video link supported the self-instruction process  
• Post-instructional summative evaluation (five questions) determined 
understanding of new information   
• Post-instructional staff survey (see Appendix C) evaluated resulting 
consistency and competency with extended infusion management 
• Post-instructional application randomly monitored by direct observation of 
administration and personal staff interviews during scheduled 
piperacillin/tazobactam therapy  
      (2)  Inter-professional Awareness 
Pilot project results were shared with pharmacist Shannon Holt, Pharmacy and 
Therapeutics Committee (P&T) Systemwide Chair, Dr. Eric Raasch, and Infectious 
Disease Specialist, Dr. Chis Ingram.  Pilot project results were presented to the Nursing 







Seventy-three nurses employed on one unit in the selected organization during the 
pilot project period were mandated by their management team to participate in this 
quality improvement pilot project.  Pertinent participant demographics regarding nursing 
experience and nursing education, described in Table 5, demonstrate the majority of 
nursing staff on the pilot unit is both highly experienced and well-educated.     
Table 5   
Experience and Education of Unit Staff Nurses  
Experience and Education of Unit Staff Nurses 
 
Experience     Nurses 
0 – 3 years     22 (30%) 
3 – 5 years         3 (4%) 
5-10 years     15 (21%) 
>10 years      33 (45%) 
 
Education       Nurses 
ADN       20 (27%)  
BSN       52 (71%) 
MSN          1 (1%) 









Implementation of the educational intervention was accomplished using an 
electronic self-instructional strategy.  This pilot was intended to determine the 
effectiveness of the self-instruction strategy in the quality improvement of the 
administration of this extended infusion.  The electronic self-instructional process could 
be easily replicated system-wide following this pilot project. The self-instruction module 
(see Appendix B) was emailed to each full- and part-time unit staff nurse (73 total nurses) 
by their unit management team.  The management team decided to mandate the self-
instruction in the interest of quality improvement.  Attestations for staff nurses to submit 
by a certain date were included in the email, however no penalty was communicated or 
planned.  Completion of the self-instruction module was mandated within the two-week 
period in March of 2018.  No additional instruction was provided to the staff nurses 
regarding the new extended antibiotic infusion procedure.  A post-instructional 
summative evaluation of five multiple choice questions and a signed attestation of 
understanding of the information presented were included in the self-instruction to be 
submitted to the unit supervisor by the end of the two-week self-instruction period. The 
project manager scored all summative evaluations to maintain participant confidentiality.  
Post-instructional application of information was randomly observed and 
evaluated by the project manager for consistency and accuracy for a three-week period.  
A checklist based on the new extended antibiotic infusion process was used throughout 
the monitoring period. The project manager monitored the process application by direct 
observation and personal staff interviews regarding variables affecting the duration of the 





rooms during the monitoring phase without any recording of patient information. 
Information regarding instruction and instruction application obtained during staff nurse 
interviews was recorded without any specific nurse identifiers. Information was observed 
on the smart pump during administration or communicated by the nurse regarding each 
randomly selected infusion to establish whether the instruction was followed.  For each 
randomly selected infusion, information about how the nurse administered the medication 
was easily reviewed using the pump keypad to establish whether the new procedure 
instructions were followed.    
An anonymous staff survey (see Appendix C) was encouraged to be completed as 
an outcome measure of this pilot project.  If staff nurses opted not to complete the 
voluntary survey, they were advised to delete it without penalty.  An explanation and 
instructions for the staff survey were emailed by the unit management team to all unit 
nurses with a Survey Monkey link. This email was resent to all unit nurses two weeks 
later.   
 An overall summary of results was presented to the Nursing Practice Council with 
recommendations for a policy update to correct infusion infractions system-wide.  Results 













 The goal of this project was to evaluate the effectiveness of a self-instruction 
module in improving the quality of the extended antibiotic infusion process.  Intended 
outcomes were to observe consistent and competent application of best practice evidence 
following self-instruction on one nursing unit during random infusion monitoring.  This 
was measured after the instruction period by direct observation of smart pump dose 
delivery settings associated with administration of random extended antibiotic infusions.  
These findings were dependent upon the self-instruction module completion by staff 
nurses and their understanding of the best-practice evidence provided.  Staff nurse 
understanding was validated using two methods, a summative multiple- choice 
assessment and a self-reporting survey.   
Instruction Effectiveness 
 First, the effectiveness of the self-instruction module was evaluated immediately 
upon completion by each staff nurse using a five-item multiple-choice summative post-
test assessment.  Of the 73 nurses who were emailed a self-instruction module, a total of 
30 (41%) nurses submitted an attestation for completing the instruction.  Each nurse 
completing the instruction responded 100% correctly to all five post-test questions (150 
questions/150 correct).   
 Second, the self-instruction effectiveness was evaluated several weeks following 
completion using an anonymous staff survey (see Appendix C).  All 73 staff nurses were 
emailed a Survey Monkey link to self-report responses indicating personal reflections 





30 nurses completing the instruction, nine nurses (30%) responded to the staff survey.  
All respondents either agreed (38%) or strongly agreed (62%) with every item.  Three 
respondents reported having administered the infusion using the new process.  No 
problems were encountered. (Table 6 & 7).   
 
Table 6   
Staff Survey Ratings 
Staff Survey Ratings 
                               
    Agree     Strongly Agree 
1.  Instructions easy to understand (knowledge)   5  4 
2.  Completion time reasonable (skill)    5  4 
3.  Infusion management awareness improved (knowledge)  4  5 
4.  Time dependent antibiotic awareness improved (knowledge) 3  6 
5.  Comfortable implementing new process (skill)   3  6 
6.  Quality improvement for patients (attitude)   2  7 
7.  Quality improvement for nursing practice  (attitude)  2  7 
       
Table 7  
Collation of Staff Survey Comments 
Collation of Staff Survey Comments 
                 Total 
Clear and easy to understand       3 
New information        1 







 Following the instructional intervention to improve staff nurse understanding of 
time dependent antibiotic administration, evaluation of consistent and competent 
application of the learning was measured.  Over a period of three weeks post-instruction, 
29 infusions were randomly selected for direct observation (see Appendix D).  All shifts 
were monitored.  Six days of the week were monitored (excluding Sunday).  Of the 
randomly observed post-instruction infusions, 17 of 29 pumps (59%) were programmed 
to infuse according to the instruction. This was evidenced by observation of the 
secondary volume to be infused (VTBI) programmed at 25 mL indicating the dead space 
volume had been deliberately adjusted by the nurse after the priming bolus.  In three of 
those observations, the VTBI remained at 50 mL, so the nurse was interviewed for 
affirmation the priming bolus had been performed.  In addition to observation and/or 
interview, a primary fluid flush rate of 12.5 mL indicated the nurse had completed the 







Figure 4.  Frequency of Primary Flush Rates after Instruction 
 
 
Measurement of Pre and Post Instruction Durations 
 The intended duration of the extended antibiotic infusion is four hours (240 
minutes).  Prior to instruction, durations ranged from 132 minutes to 144 minutes.  This 
means that durations of the infusions ranged from 55% to 60% of the duration that was 
ordered to be administered.  No infusions were found to be accurately delivering the four-
hour duration as ordered.  
Shortest durations: 
The shortest infusions flushed for 12 minutes (20 mL at 100 mL/hr). 
Longest durations: 























Frequency of Primary Flush Rates 





 Following the instruction period, 17 extended infusions were observed being 
administered according to the instruction.  These infusion durations were 240 minutes or 
100% the four-hour duration as ordered.  Therefore, post-instruction, 100% of infusions 
were found to be accurately delivering the therapeutic four-hour duration.  The remaining 
monitored infusions varied in shortened duration ranges consistent with pre-instruction 
findings.   
Measurement of Pre and Post Instruction MIC 
 The intended infusion duration for piperacillin/tazobactam is T > 50% at MIC, or 
50% of the eight hour dosing interval at the minimum inhibitory concentration. Prior to 
instruction, the shortest infusions flushed for 12 minutes (20 mL at 100 mL/hr) or 28% at 
MIC.  The longest infusions flushed for 24 minutes (20 mL at 50 mL/hr) or 30% at MIC.  
The average of these, 29% at MIC, represents an overall shortened and sub-therapeutic 
pre-instruction infusion process.  In comparison, the post-instruction 50% at MIC 
















































Interpretation of Findings 
Instruction Effectiveness Evaluation 
 Interpretation of project findings substantiates the overall effectiveness of the self-
instruction module in improving extended antibiotic infusions.  Based on post-test results 
immediately following instruction and staff surveys weeks later, nurses associated the 
instruction with individual understanding of the new information.  One hundred percent 
of 150 post-test questions were answered correctly by nurses upon completing the 
instruction.  In addition, nurses responding positively to the staff survey several weeks 
following instruction indicates retention of the new information.   
 A staff survey response of 30% represents a typical and acceptable rate.  Survey 
items investigated individual nursing knowledge (items 1,3, and 4), skill (items 2 and 5), 
and attitude (items 6 and 7) of the respondents about the instruction.  Respondents 
unanimously indicated positive opinions toward the self-instruction and its application to 
their practice.  Likert ratings for the first seven survey items vary slightly.  More 
respondents agreed with items associated with ease and effort (2 of 7) than strongly 
agreed.  More respondents strongly agreed with remaining items (5 of 7) than agreed.  
This suggests consideration and evaluation on the part of the respondents prior to 
selecting their responses.  Respondents consistently value the overall instruction and feel 
confident to apply their new learning to patient care.  In addition, respondents 
unanimously recognize system-wide benefit to the instruction. 
 Collation of survey comments also supported the positive overall response to the 





of the infusion infractions.  One nurse’s expression of concern over tiny bubbles resulting 
from the priming bolus speed is worth noting.  This nurse preferred to prime the tubing at 
a rate of 400mL/hour and clamp the primary tubing with an instrument clamp for the four 
minutes the prime takes at that rate.  This is an individual nurse preference that in no way 
alters the infusion duration from the new procedure.  
Instruction Limitations 
 Two limitations were identified during the implementation of this pilot project 
that had a significant effect on the instruction.  Both limitations were related to the 
accessibility of the instruction module for completion by the unit nurses.  The first 
limitation was the ineffective email delivery to the nurses.  Emails delivered to the nurses 
were not necessarily visible to the nurses.  The email issue was discovered when the 
instruction period concluded with only 16 of 73 attestations for completing the mandated 
instruction.  Further investigation revealed the enormous quantity of emails received 
daily by each nurse.  The overwhelming quantity resulted in the habitual neglect of 
nurses to check their email.  Hypothetically, if a nurse failed to check email for two days, 
that nurse would likely never see a mandated item.   In this case, the nurses were 
anticipating the mandated instruction introduced by their management team, yet the 
majority of nurses never realized it had arrived.  The instruction period was extended for 
an additional two weeks to allow more nurses an opportunity for completion.   
 As the monitoring phase began, it became clear that many nurses had still not 
seen the instruction module.  During this time, a second limitation was identified.  Float 
pool nurses were regularly assigned to the pilot unit throughout the pilot project period.  





therefore, could not complete the instruction.  Notations were made when a float pool 
nurse was identified as administering the infusion during the monitoring period.  Though 
these limitations were identified, they had no direct bearing on the overall results, as only 
the data from nurses who had completed the instruction were examined, collated, and 
considered.    
 Instruction effectiveness findings validate the achievement of instruction 
understanding by the nurses who attested to completing the self-instruction module.  This 
is evidenced by perfect post-test scores as well as individual nurse reporting in survey 
responses.  The instruction application evaluation demonstrates the post instruction 
consistency and competency of nurses during random infusion monitoring.   
Instruction Application Evaluation 
 Direct observation of 29 randomly selected infusions validated consistent and 
competent application of the new extended infusion procedure by staff nurses post 
instruction.  This was evidenced by 100% of nurses demonstrating capability and 
accuracy in using the new procedure throughout the three-week post instruction 
monitoring period.  In addition, despite limitations in accessibility of the self-instruction, 
infusions programmed for 100% of the duration ordered increased by 72% post 
instruction. 
  The duration problem created by the DSV is two-fold on both the front and back 
ends of the extended infusion.  Nurses must demonstrate that the infusion is primed to the 
patient’s infusion site before beginning the infusion.  Nurses must also demonstrate that 
the infusion is flushed at the same rate of the infusion while residual dead space volume 





primed and flushed accurately using the new procedure. Since no nurses were found to 
prime or flush infusions accurately pre-instruction and the procedure in the instruction is 
new to the nurses, accurate use of the new procedure post-instruction indicates 
completion of the instruction.  Therefore, of the nurses indicating completion of the self-
instruction with accurate programming of their smart pump, 100% demonstrate consistent 
and competent application of instruction.   
 A comparison of pre and post instruction durations also substantiates the 
consistent and competent application of instruction by the nursing staff.  Seventeen 
infusions observed delivering the complete four-hour duration post instruction quantifies 
the effectiveness of the self-instruction.  In terms of the MIC required for effective 
therapeutic patient benefit, findings are consistent.  The average range of infusion 
duration pre-instruction translates to an average of 29% at MIC, which is significantly 
sub-therapeutic.  The post-instruction duration of 50% at MIC represents delivery of the 
complete duration of medication as ordered in 100% of observations.  The difference in 
duration time at MIC pre and post instruction demonstrates an improvement of 72% in 
the therapeutic duration delivery of piperacillin/tazobactam (50-29 = 21; 21/29 = 72% 
duration improvement). 
Comparison to Literature 
Nursing-led implementations such as this pilot project were not encountered in 
the literature.  Infusion-associated implementations are most often pharmacy-led efforts 
due to the pharmacological impacts involved.  Inter-professional collaboratives 
surrounding infusion administration should optimally include nursing input.  The 





Gaps also continue to surround the recognition of beneficial support opportunities 
involving smart pump safeguards and capabilities.   
A sustainable system-wide implementation to improve extended antibiotic 
infusions will require an ongoing awareness of and sensitivity to variations among 
individuals and groups involved with the change.  It is important to involve persons who 
are considering a practice change in identifying the problems as well as determining an 
action plan.  The change process will be a deliberate buy-in choice for each staff member.  
Porter-O’Grady and Malloch (2015) warned that variables including readiness for change 
and subtle group dynamics could influence stakeholders throughout the change process 
and should be closely monitored.  The Society of Critical Care Medicine (2017) 
recognized two helpful strategies when implementing a practice initiative.  One 
recommended strategy was to minimize the number of steps associated with the change.  
The second strategy was to maintain consistency among the steps whenever possible to 
minimize the risk of confusion or misinterpretation.  These strategies were respected 
during the development of the new infusion procedure included in this pilot project.   
Comparison to Swanson’s Theory of Caring 
 Kristen Swanson clearly outlined the ideal framework supporting this pilot project 
to improve extended antibiotic infusions.  Inaccurate delivery of infusion therapy is a 
nursing practice issue that impacts client well-being, one of the four phenomena she 
identified as common to nursing practice.  The five caring processes direct nurses toward 
a therapeutic outcome that recognized nursing knowledge as integral to tailoring 





processes, sustain the nursing responsibility for optimizing an infusion process that 
patients perceive to be ideal in meeting their therapeutic needs.    
 
Recommendations 
 As a result of this scholarly pilot project, several recommendations associated 
with the practice problem and proposed solution are indicated.  Findings validate the 
effectiveness of the self-instruction module in improving the delivery of extended 
antibiotic infusions.  Nurses are consistently and competently applying the new infusion 
procedure to their practice following completion of the self-instruction module.  First, 
system-wide instruction should be mandated to improve the extended antibiotic infusion 
process to that which is ordered, expected, and therapeutic for patients.  Next, strategies 
other than a single email must be used to make the instruction accessible to all nurses.  
Third, a demonstration video provided with the self-instruction module was never 
mentioned by any of the nurses.  Instruction on a larger scale would be best supported by 
a video with enhanced visibility so that visual learners could benefit by being able to read 
the smart pump settings.   
 A few minor alterations were made to the new infusion procedure following staff 
surveys, direct observation, and interviews of the nurses.  A majority of survey 
respondents felt least agreeable with ease and effort items, so adjustments were made to 
shorten the overall written procedure.  These alterations were included in the procedure 
presented to the Nursing Practice Council.  No backpriming is needed prior to priming 
the infusion tubing with medication.  This is, however, a difference in procedure from 





the nurse preferred to continue the routine.  Backpriming is still a requirement when 
changing the secondary tubing.  The VTBI was altered to match the secondary and 
primary programming.  With this alteration, the nurse would more easily program both 
the secondary and primary bags with the same rates and VTBI.  The option to slow the 
priming bolus rate was added along with the rationale that it lengthens the priming time.  
Some nurses prefer to slow the priming bolus; this does not affect the infusion duration.  
The option for nurses to clamp or pinch primary tubing during the priming bolus also has 
no effect on the infusion duration.  Disconnection of the infusion tubing between 
infusions was also recommended for enhanced patient mobility. 
Conclusion 
 The solution to the practice problem including a new infusion procedure was 
piloted on one unit and evaluated for efficacy.  Results and recommendations regarding 
system-wide implementation were presented to the Nursing Practice Council in May of 
2018 and are currently being considered.  The proposed medication bolus into the tubing 
serves to redefine the beginning of the extended antibiotic infusion to that which was 
ordered for the duration which was ordered.  The intended beginning of an antibiotic 
infusion is the patient’s intravascular space, not the infusion tubing.  This redefinition 
should be recognized by nurses system-wide for the accurate administration and 
consistent delivery of time dependent medications over the duration periods ordered by 
physicians.   
Documentation appeared that infusions were administered correctly over four 
hours as ordered, but direct observation at bedsides revealed that was not true.  Direct 





improvement in duration delivery despite significant issues regarding accessibility of the 
instruction.   
 This scholarly practice project is intended to culminate in a system-wide 
awareness of a significant practice problem with direct impact on the success of clinical 
patient outcomes.   Although assessment of clinical outcomes would exceed the scope of 
this project, the educational intervention pilot to redefine the appropriate beginning of the 
extended antibiotic infusion is a sustainable solution to this practice problem.  The quality 
improvement of extended infusions on the pilot unit following self-instruction is 
significant.  Recommendations resulting from this redefinition pilot project are intended 
to facilitate a system-wide extended infusion policy update to improve the delivery of 


















Alexander, E., & Zomp, A. (2015). Best practices:  Full-dose delivery of intravenous 
medications via infusion pumps.  Critical Care Nurse, 35(15)68-70.  doi:  
http//dx.doi.org/10.4037/ccn2015388 
American Nurses Association (ANA)/Centers for Disease Control and Prevention (CDC). 
(2017).  Redefining the antibiotic stewardship team: Recommendations from the 
American Nurses Association/Centers for Disease Control and Prevention 
workgroup on the role of registered nurses in hospital antibiotic stewardship 
practices. Retrieved from http://www.nursingworld.org/ANA-CDC-
AntibioticStewardship-WhitePaper 
Butts, J. B. & Rich, K. L. (2015). Philosophies and theories for advanced nursing 
practice (2nd ed.). Burlington, MA:  Jones & Bartlett Learning. 
Buyle, F., Decruyenaere, J., De Waele, J., Tulkens, P., Van Audenrode, T., Depuydt, P. . . 
. & Vogelaers, D. (2013). A survey of beta-lactam antibiotics and vancomycin 
dosing strategies in intensive care units and general wards in Belgian hospitals. 
European Journal of Clinical Microbiology & Infectious Diseases: Official 
Publication of the European Society of Clinical Microbiology, 32(6), 763-768. 
doi:10.1007/s10096-012-1803-7   
Callahan, B. (2015). Clinical nursing skills: A concept-based approach to learning (Vol. 
3, 2nd ed.). Boston, MA: Pearson. 
Centers for Disease Control and Prevention (CDC). (2017). Antibiotic/Antimicrobial 





Deglin, J., & Vallerand, A. (2015). Davis’s drug guide for nurses 2015 (15th ed.). 
Philadelphia, PA:  F.A. Davis Company. 
Droege, M., Van Fleet, S., & Mueller, E. (2016).  Application of antibiotic 
pharmacodynamics and dosing principles in patients with sepsis.  Critical Care 
Nurse, 36(2), 22-32.  doi:  http://dx.doi.org/10.4037/ccn2016881 
Falagas, M., Tansarli, G., Ikawa, K., & Vardakas, K. (2013). Clinical outcomes with 
extended or continuous versus short-term intravenous infusion of carbapenems 
and piperacillin/tazobactam: A systematic review and meta-analysis. Clinical 
Infectious Diseases, 56(2), 272-282.  
Fan, S., Shum, H., Cheng, W., Chan, Y., Leung, S., & Yan, W. (2017). Clinical outcomes 
of extended versus intermittent infusion of piperacillin/tazobactam in critically ill 
patients:  A prospective clinical trial. Pharmacotherapy:  The Journal of Human 
Pharmacology and Drug Therapy, 37(1), 109–119) doi: 10.1002/phar.1875 
Field, B., Booth, A., Ilott, I., & Gerrish, K. (2014). Using the knowledge to action 
framework in practice: A citation analysis and systematic review.  Implementation 
Science: IS, 9(1), 172. doi:10.1186/s13012-014-0172-2 
Heinrich, L. S., Tokumaru, S., Clark, N. M., Garofalo, J., Paek, J. L., & Grim, S. A. 
(2011). Development and implementation of a piperacillin-tazobactam extended 








Institute for Safe Medication Practices (ISMP). (2009). Proceedings from the ISMP 
summit on the use of smart infusion pumps: Guidelines for safe implementation 
and use. 1-19. Retrieved from  http://www.ismp.org/tools/guidelines/smartpumps/ 
Institute for Safe Medication Practices (ISMP). (2018). Smart pumps in practice: 
Survey results reveal widespread use, but optimization is challenging.  
Retrieved from https://www.ismp.org/resources/smart-pumps-practice-survey-
results-reveal-widespread-use-optimization-challenging 
Kim, A., Kuti, J. L., & Nicolau, D. P. (2009). Probability of pharmacodynamic target 
attainment with standard and prolonged-infusion antibiotic regimens for empiric 
therapy in adults with hospital-acquired pneumonia. Clinical Therapeutics, 
31(11), 2765-2778.  doi: 10.1016/j.clinthera.2009.11.026 
Kirkbride, G., & Vermace, B. (2011). Smart pumps: Implications for nurse leaders. 
Nursing Administration Quarterly, 35(2), 110. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/21403484 
Lam, W., Bhowmick, T., Gross, A., Vanschooneveld, T., & Weinstein, M. (2013). Using 
higher doses to compensate for tubing residuals in extended-infusion piperacillin-
tazobactam. Annals of Pharmacotherapy, 47(6), 886-891. doi:10.1345/aph.1R721  
Lee, G., Liou, H., Yee, R., Quan, C., & Neldner, K. (2012). Outcomes of extended-
infusion piperacillin-tazobactam:  A retrospective analysis of critically ill patients.  







Lodise, T., Lomaestro, B., & Drusano, G. (2007). Piperacillin-tazobactam for 
pseudomonas aeruginosa infection: Clinical implications of an extended-infusion 
dosing strategy.  Clinical Infectious Diseases, 44(3), 357-363.  Doi: 
10.1086/510590 
 Maddox, M., DeBoer, E., & Hammerquist, R. (2014). Administration of extended 
infusion piperacillin-tazobactam with the use of smart pump technology. Hospital 
Pharmacy, 49(5), 444-448. doi:10.1310/hpj4905-444 
Manning, M.L. (2016). Antibiotic stewardship for staff nurses: Five key ways you can 
influence antibiotic use.  American Nurse Today, 11(5), 12–14. Retrieved from 
https://americannursetoday.com/wp-content/uploads/2016/05/ant5-Antibiotics-
420.pdf 
Manning, M. L., Pfeiffer, J., & Larson, E. L. (2016). Combating antibiotic resistance: The 
role of nursing in antibiotic stewardship. American Journal of Infection Control, 
44, 1454-1457. doi: 10.1016/j.ajic.2016.06.023 
Monsees, E., Goldman, J., & Popejoy, L. (2017). State of the science review: Staff nurses 
as antimicrobial stewards: An integrative literature review. AJIC: American 
Journal of Infection Control, 45, 917-922. doi: 10.1016/j.ajic.2017.03.009 
Morgan, S. A. (2017). Strengthening nurses' role in antibiotic stewardship. American 
Nurse Today, 12(10), 37. ISSN: 19305583 
Ohashi, K., Dalleur, O., Dykes, P., & Bates DW. (2014). Benefits and risks of using 
smart pumps to reduce medication error rates: a systematic review.  Drug Safety, 





Olans, R.N., Olans, R.D., & DeMaria, A. (2016). The critical role of the staff nurse in 
antimicrobial stewardship—Unrecognized, but already there. Clinical Infectious 
Diseases, 62(1), 84–89. http:// dx.doi.org/10.1093/cid/civ697 
Pedersen, C., & Gumpper, K. (2008). ASHP national survey on informatics: assessment 
of the adoption and use of pharmacy informatics in U.S. hospitals--2007. 
American Journal of Health-System Pharmacy, 65(23), 2244-2264. 
doi:10.2146/ajhp080488 
Porter-O’Grady, T. & Malloch, K. (2015).  Quantum leadership:  Building better 
partnerships for sustainable health, (4th ed.). Burlington, MA:  Jones & Bartlett 
Learning. 
Reston, J. (2013).  Smart pumps and other protocols for infusion pumps: Brief review.  
In: Making health care safer II: An updated critical analysis of the evidence for 
patient safety practices. Bethesda, MD: National Center for Biotechnology 
Information.  Retrieved from 
https://www.ncbi.nlm.nih.gov/books/NBK133356/?log$=activity 
Schmees, P., Bergman, S., Strader, B., Metzke, M., Pointer, S., & Valenti, K. (2016). 
Outcomes of an extended-infusion piperacillin-tazobactam protocol 
implementation in a community teaching hospital adult intensive care unit. 
American Journal of Health-System Pharmacy, 73(11), S100-S105.  Doi: 
10.2146/sp150041 






Stanford Health Care, Pharmacy Department Policies and Procedures. (2015). Medication 




Swanson, K. M. (1991).  Empirical development of a middle range theory of caring.  
Nursing Research, 40(3), 161-166.  Retrieved from 
http://www.watsoncaringscience.org/images/features/library/Empirical%20Devel
opment.pdf 
Swanson, K. M. (1993).  Nursing as informed caring for the well-being of others. Journal 
of Nursing Scholarship, 25(4), 352-357.  Retrieved from 
http://nursing.unc.edu/files/2012/11/ccm3_032549.pdf 
The Joint Commission. (2016). Approved:  New antimicrobial stewardship standard. 
Joint Commission Perspectives, 36(7), 1-4.  
https://www.jointcommission.org/assets/1/6/New_Antimicrobial_Stewardship_St
andard.pdf 
Trbovich, P., Pinkney, S., Cafazzo, J., & Easty, A. (2010).  The impact of traditional and 
smart pump infusion technology on nurse medication administration performance 
in a simulated inpatient unit.  Quality & Safety in Health Care, 19(5), 430–434. 







Trbovich, P., Cafazzo, J., & Easty, A. (2013). Implementation and optimization of smart 
infusion systems: Are we reaping the safety benefits? Journal for Healthcare 
Quality, 35(2), 33-40. 10.1111/j.1945-1474.2011.00175.x  
Yost, R. J., & Cappelletty, D. M. (2011). The retrospective cohort of extended-infusion 
piperacillin-tazobactam (RECEIPT) study: A multicenter study. 
Pharmacotherapy, 31(8), 767-775. doi:10.1592/phco.31.8.767 
Yui Tsang, K. C. (2015). Development and assessment of an interactive training tool to 
help reduce error rate associated with shared infusion volume management tasks. 
Available from Dissertations & Theses @ Library and Archives Canada. 
Retrieved from https://search.proquest.com/docview/1752246942 
Yusuf, E., Spapen, H., & Piérard, D. (2014). Prolonged vs intermittent infusion of 
piperacillin/tazobactam in critically ill patients: A narrative and systematic 







Literature Review Matrix 
Author Title Journal Purpose Key Points Evaluation of Article       
Alexander, E., & 
Zomp, A 
Best practices:  Full-dose 
delivery of intravenous 
medications via infusion 
pumps. 
Critical Care Nurse Raises awareness of dead space 
infusion tubing volumes and 
residual IVPB overfill and 
examines dose precision and 
potential clinical significance  
Doses delivered using only 
primary tubing less suitable for 
smaller total dose volumes due to 
significant dose residual in 
tubing.  
For the specific 50mL preparation of 
Piperacillin/tazobactam used in 
project organization, up to 60% of 
the dose can be lost to residual 
tubing volume post infusion.  
Claus, B., Buyle, F., 
Robays, H., & 
Vogelaers, D. 
Importance of Infusion 
Volume and Pump 
Characteristics in Extended 





Discusses common practice 
dilemmas of infusion line dead 
space and residual dose loss in a 
Belgian hospital 
Up to 40% of antibiotic dose lost 
if tubing not flushed following 
dose (replacement of line dead 
space) versus not replacing 
deadspace as with primary tubing 
risks infusion of degraded drug 
with next infusion.    
Dilemmas must be addressed with 
implementation of new infusion 
protocols. 
Droege, M., Van 
Fleet, S., & Mueller, 
E. 
Application of antibiotic 
pharmacodynamics and dosing 
principles in patients with 
sepsis.   
Critical Care Nurse Update for nurses about 
antibiotic pharmacotherapy in 
association with sepsis 
Administration strategies are 
integral in achieving optimal 
patient outcomes. 
Researchers update nurses about 
best evidence regarding antibiotic 
therapy with direct application to the 
physiology of sepsis.  Education 
includes time vs concentration 
dependency, or both.  
Falagas, M., 
Tansarli, G., Ikawa, 
K., & Vardakas, K.   
Clinical outcomes with 
extended or continuous versus 
short-term intravenous 
infusion of carbapenems and 
piperacillin/tazobactam: A 




Review of 14 studies of 1229 
patients to determine whether 
longer durations of 
piperacillin/tazobactam or 
carbapenem infusions were 
associated with decreased 
mortality 
Patients with either pneumonia or 
other infections demonstrated 
significantly lower mortality with 
extended or continuous 
piperacillin/tazobactam infusions 
than with short-term infusions.  
Only 3 of 14 were RCTs but 
randomization may be difficult. 
Researchers reviewed PK and PD 
properties; Both are time-dependent 
antibiotics where the duration of 
intravascular exposure of the 
pathogen to the antibiotic determines 
the clinical effectiveness.  
Carbapenems = 40% MIC and 
piperacillin tazobactam = 50% MIC.  
Short-term infusions may allow 
pathogens to mutate into resistant 
strains. 
Fan, S., Shum, H., 
Cheng, W., Chan, 
Y., Leung, S. M., & 
Yan, W 
Clinical outcomes of extended 
versus intermittent infusion of 
piperacillin/tazobactam in 
critically ill patients: A 
prospective clinical trial.  
Pharmacotherapy: 




single layer open-label 
prospective study in Hong Kong 
367 pts in a 22 bed ICU in Hong 
Kong received Pip/taz for at least 
48 hrs; 182 EI and 183 non EI; 
Significant (p=.01)14day 
mortality benefit in EI vs 30min 







Felton, T., Hope, 
W.,  Lomaestro, B., 
Butterfield, J., Kwa, 
A., Drusano, G., &  




hospitalized patients with 




Investigation of the pip/taz 
pharmacokinetic influences 
Assurance that T>50%MIC was 
observed 
Extended pip/taz infusions 
determined to be best practice for 
treatment of nosocomial infections 
Harding, A. D.  Increasing the use of 'smart' 
pump drug libraries by nurses: 
A continuous quality 
improvement project. 
The American 
Journal of Nursing 
   
Heinrich, L. S., 
Tokumaru, S., Clark, 
N. M., Garofalo, J., 
Paek, J. L., & Grim, 
S. A.  
Development and 
implementation of a 
piperacillin-tazobactam 
extended infusion guideline.  
Journal of 
Pharmacy Practice 
500 bed academic medical 
center;103 patients and 1215 
pip/taz doses 
Included dose, staff education, 
and implementation issues shared 
as lessons learned; pharmacist led 
development and implementation.  
Each infusion monitored at each 
bedside for 5 weeks to ensure 
compliance with new guidelines and 
to make immediate corrections.  
Rates increased from 25 to 30mL/hr 
to complete 100 mL dose. 
Kim, A., Kuti, J. L., 
& Nicolau, D. P.  
Probability of 
pharmacodynamic target 
attainment with standard and 
prolonged-infusion antibiotic 
regimens for empiric therapy 




Studied 5000 patients Pip/taz least effective for all 
monotherapy studied but studied 
in Monte Carlo Sim as extended 
infusion 
3 hr extended infusions of pip/taz 
not as effective as extended 
infusions of other beta lactams 
against late HAP, but all more 
effective than short infusions. 
Kirkbride, G., & 
Vermace, B. 
Smart pumps: Implications for 









& Weinstein, M.  
Using higher doses to 
compensate for tubing 




   
Lee, G. C., Liou, H., 
Yee, R., Quan, C. F., 
& Neldner, K.  
Outcomes of extended-
infusion piperacillin-
tazobactam: A retrospective 




148 pts in critical care studied 
for the purpose of comparing EI 
versus TI pip/taz infusion 
effectiveness 
Retrospective pre and post 
implementation study in Texas 
comparing extended and 
traditional pip/taz 
Extended dosing strategy associated 
with an improved 30 day mortality 
thus may be an effective alternative 
strategy in gram neg infections in 










infection: Clinical implications 




Cohort study of 194 patients 
with pseudomonas infections;   
  
Maddox, M., 
DeBoer, E., & 
Hammerquist, R.  
Administration of extended 
infusion piperacillin-
tazobactam with the use of 
smart pump technology.  
Hospital Pharmacy Converted all pip/taz infusions 
to 4 hr every 8-12 hrs with 
smart pump technology.   
Standardization to promote 
consistency and prevent 
administration errors. 
Decreased average LOS (not sigif) 
but signif decrease in mortality; 
conservative cost savings estimate in 
24 months of over $2 million. 
Ohashi, K., Dalleur, 
O., Dykes, P., & 
Bates DW.  
Benefits and risks of using 
smart pumps to reduce 
medication error rates: a 
systematic review.   
Drug Safety Addresses smartpumps and med 
error reduction 
  




intermittent and prolonged 
infusions of 
piperacillin/tazobactam using 
monte carlo simulation and 
steady-state pharmacokinetic 
data from hospitalized 
patients. 
The Annals of 
Pharmacotherapy 
   
Schmees, P., 
Bergman, S., 
Strader, B., Metzke, 
M., Pointer, S., & 
Valenti, K. 
Outcomes of an extended-
infusion piperacillin-
tazobactam protocol 
implementation in a 
community teaching hospital 
adult intensive care unit.  
American Journal of 
Health-System 
Pharmacy 





Mininni, N., Ervin, 
K., & Urban, A.  
Quality-improvement analytics 
for intravenous infusion 
pumps.  
American Journal of 
Health-System 
Pharmacy 





Trbovich, P. L., 
Cafazzo, J. A., & 
Easty, A. C.  
Implementation and 
optimization of smart infusion 
systems: Are we reaping the 
safety benefits?  
Journal for 
Healthcare Quality 
Experimental study to test smart 
pump technology effects on 
medication administration 
safety.  Recognizes 
programming errors despite 
hard limits of programmed drug 
libraries.  
24 nurses were observed using 3 
types of pumps and 7 repeated 
tasks (four intermittent and 3 
continuous infusion tasks) so 
each participant completed 21 
infusion tasks. 
Recognizes programming errors 
despite hard limits of programmed 
drug libraries.  
Trbovich, P., 
Pinkney, S., 
Cafazzo, J., & Easty, 
A. 
The impact of traditional and 
smart pump infusion 
technology on nurse 
medication administration 
performance in a simulated 
inpatient unit.   
Quality & Safety in 
Health Care 
   
Winstead, E., 
Ratliff, P., Hickson, 
R., Mueller, J., & 
Judd, W.  
Evaluation of an alternative 
extended-infusion piperacillin–
tazobactam dosing strategy for 
the treatment of gram-negative 
infections.  
International 
Journal of Clinical 
Pharmacy 
 To assess the clinical and 
economic impact of a novel 3-h 
extended-infusion piperacillin–
tazobactam dosing strategy for 
the treatment of gram-negative 
infections.  
433 bed hospital in Kentucky;  
retrospective cohort study before 
and after implementation;  181 
pts received pip/taz for at least 48 
hrs.   
Significantly (p=.002) reduced 30-
day readmission with 3hr extended 





Caquelin, C., & 
Schwartz, D.  
Implementation of an 
extended-infusion piperacillin–
tazobactam program at an 
urban teaching hospital.  




Emphasis on quality assurance 
outcomes with institution of new 
extended pip/taz protocol 
Yost, R. J., & 
Cappelletty, D. M. 
The retrospective cohort of 
extended-infusion piperacillin-
tazobactam (RECEIPT) study: 
A multicenter study.  
Pharmacotherapy RECEIPT Study (retrospective 
cohort of extended infusion 
pip/taz) with signif decrease in 
hosp mortality; 359 adults; 
multicenter retrospective 
medical record review; 14 
hospitals selected varied in size 
and location to best represent 
broad population. 
The primary outcome was 
mortality rate of the patients 
receiving extended infusion 
piperacillin-tazobactam versus 
those receiving non-extended 
infusion comparative antibiotics.  
Extended pip/taz infusions 
demonstrated decreased mortality in 
the treatment of patients with gram-
negative infections; Decreased 






Yui Tsang, K. C.  Development and assessment 
of an interactive training tool 
to help reduce error rate 
associated with shared infusion 









Theses @ Library 
and Archives 
Canada 
Purpose of study was to develop 
and validate a training sim for 
critical care nurses to enhance 
decision-making regarding 
infusion volume management; 
intensive undertaking for 25 
nurses at many levels.  Trbovich 
was the faculty lead. 
>200 page dissertation with 
complex simulation initiative to 
enhance shared infusion volume 
reasoning of 25 critical care 
nurses. 
More complex simulation tool for 
critical care nurses but the 
underlying infusion volume 
management issues are the same. 
Yusuf, E., Spapen, 
H., & Piérard, D.  
Prolonged vs intermittent 
infusion of 
piperacillin/tazobactam in 
critically ill patients: A 
narrative and systematic 
review.  
Journal of Critical 
Care 
Systematic review comparing 
the effectiveness of extended 
versus continuous pip/taz 
infusions in Belgium.  Moderate 
level of evidence (1 high quality 
RCT and at least 2 high quality 
retrospective studies show 
similar results) supporting the 
prolonged or extended pip/taz 
infusion as having better clinical 
outcomes than with intermittent 
infusions and should be 
preferred for critically ill 
patients. 
The studies in the review were 
global but the RCT was done in 
the US (Lee et al 2012) 
Excellent validation of extended 
pip/taz as best practice!  Moderate is 









Quality Improvement of the Extended Antibiotic Infusion Administration Process:   
A Self-Instruction Module  
 
 
Patricia Averre, MSN, RN, CNE 
 























Quality Improvement of the Extended Antibiotic Infusion Administration Process:   
A Self-Instruction Module  
 
Introduction 
 Extended antibiotic infusions, primarily four-hour piperacillin/tazobactam 
(Zosyn), were added to pharmacotherapy options at this hospital in 2010.  Since then, 
several issues have emerged that jeopardize intended patient outcomes to extended 
infusion therapy.  This project will pilot an educational initiative to inform nursing staff 
on one unit of current best practice evidence affecting extended antibiotic infusion 
management.  
 This self-instruction module will review time-dependent antibiotic use and current 
administration issues.  An intervention will be introduced to redefine the beginning of 
extended infusions in relation to the patient and improve dose delivery for the duration 
periods ordered. The most important part of this self-instruction module will be its 
consistent application following completion.  Please begin using this information 
immediately to improve the delivery of four-hour piperacillin/tazobactam (Zosyn) 
infusions for patients.     
 
Purpose  
 The purpose of this instruction module is to improve the delivery of four-hour 
piperacillin/tazobactam (Zosyn) infusions using nursing management and stewardship 
strategies for consistent and compliant dose delivery needed by patients experiencing 
infections.    
 
Objectives 
Upon completion of this self-instruction module, participants will be able to: 
1. Corroborate time-dependent antibiotics and clinical benefits to patients. 
2. Redefine the beginning of the medication infusion in relation to the patient’s 
intravascular space. 
3. Document the beginning of the medication infusion in relation to the patient’s 
intravascular space.   
4. Ensure the four-hour duration of extended infusions in relation to the patient’s 
intravascular space.  
 
Instructions 
1. Review the self-instruction module at your convenience within the designated 
two-week period:  2/28/18 through 3/14/18 
2. Answer the post-instruction questions and sign the attestation form.  Submit both 
the test and attestation to Megan Swink by Wednesday, March 14, 2018.   
3. Piperacillin/tazobactam infusion administration will be randomly monitored by 
direct observation and interview for a four-week period to evaluate the 
effectiveness of this instruction. 
4. Complete an anonymous survey within four weeks of instruction to help improve 
the content of this module.  The survey link will be emailed to all unit nurses via 






Why are extended antibiotic infusions important? 
 Dynamic issues associated with infection create unprecedented demands for 
quality healthcare improvements and modifications. Prior to 2010, researchers found 
extended antibiotic infusions to be an effective treatment option with astounding cost 
savings.1-3 As global extended antibiotic use increased, significant correlations between 
extended infusions, decreased mortality, and shortened lengths of stay have dominated 
the literature.4-14 Advantages of extended infusions have clearly evolved beyond cost-
savings.  Piperacillin/tazobactam is a broad spectrum antibiotic but is currently one of the 
best defenses against gram negative infection.  Extended piperacillin-tazobactam 
infusions are most commonly selected to target susceptible hospital associated infections 
such as fluoroquinolone-resistant Pseudomonas aeruginosa, Klebsiella pneumoniae, 
Escherichia coli, or carbapenem-resistant Enterobacteriaceae (CRE).1  
Antibiotic therapy has historically been guided by bacterial susceptibility to a 
certain antibiotic.  Multi drug-resistant organisms (MDROs) to the most commonly used 
antibiotics have resulted in the emergence of alternative dosing strategies, such as the 
extended antibiotic infusion.1,5  Certain antibiotics have proven in vitro to be most 
bactericidal when infused over an extended period, making them time-dependent 
antibiotics.1,5,6,9  Minimal drug concentrations are needed to inhibit bacterial growth, but 
concentrations must remain constant for an extended duration in the bloodstream to 
effectively destroy bacteria. The time for effective bacterial killing established for 
piperacillin/tazobactam is 50% duration of the dosing interval (or four of the eight hour 
interval).1-3  Receiving the entire dose too quickly interrupts bacterial exposure to the 
minimal inhibitory concentration (MIC) required to prevent bacterial growth (see Figure 
1).1,5,6 Therefore, although a bacterial pathogen may be susceptible to an antibiotic and 
the entire dose is administered, bacteria are given the opportunity to multiply between 
antibiotic doses.  In a study of 5000 patients with hospital associated pneumonia, 
researchers found that three-hour piperacillin/tazobactam infusions were not as effective 
as other beta-lactams; but all were more effective than 30-minute duration infusions.2 
Administering time-dependent antibiotics too quickly has been associated with longer 
hospital stays and with greater mortality.5,12  
In a cohort study of 194 patients with pseudomonas infections, Lodise, 
Lomaestro, and Drusano (2007) were the first to associate significant mortality and 
length of stay benefits with extended piperacillin/tazobactam infusions.  Falagas et al. 
(2013) shared a meta-analysis reviewing fourteen studies of over 1200 patients and their 
findings relating extended antibiotic infusions to clinical outcomes.  
Piperacillin/tazobactam effectiveness was consistently enhanced with extended infusion 
durations. Significantly decreased mortality and lengths of stay were demonstrated. These 
findings continued to be corroborated by multiple researchers as extended infusions were 
integrated into global healthcare settings.9-11,13,14 
Once piperacillin/tazobactam has been ordered as an extended infusion, it is 
critical that the infusion time begins when the antibiotic begins infusing into the patient’s 
intravascular space.  It is just as critical that the infusion duration continues to infuse 
slowly into the bloodstream for the entire four-hour period.12,15 Alexander and Zomp 
(2015) reported up to 60% of the piperacillin/tazobactam dose can be lost to residual dead 
space volume.  When the medication bag is empty, the dead space volume still contains a 





What does this mean for nurses? 
Stewardship 
 MDROs are the result of inconsistent and ineffective antibiotic usage.17 Antibiotic 
stewardship refers to the deliberately organized interprofessional strategies to ensure 
optimal antibiotic usage in combating infectious diseases, and includes unprecedented 
nursing implications.16-21 The American Nurses Association (ANA) and CDC have 
collaborated to emphasize the need for nursing involvement in antibiotic stewardship to 
improve antibiotic use in healthcare settings.16  The CDC (2017) developed four core 
actions, including stewardship, to guide professionals in combating antibiotic resistance.  
The Joint Commission (2016) established a new standard for medication management 
teams in hospitals as of January 1, 2017, specifically requiring antimicrobial stewardship 
action in controlling MDROs. 22 
Dead Space 
 Dead space refers to the volume of the intravenous infusion pathway a solution 
travels from exiting its original container until reaching the patient’s intravascular space.8 
Nurses manage dead space volume with every infusion.  The amount of dead space is 
most significant when the infusion volume is small (less than 100 mL) and rates are slow 
(less than 20 mL/hour).15 Dead space must be completely displaced by 
piperacillin/tazobactam before the medication arrives at the patient’s intravascular space.  
Without this displacement, the slow rate of the extended infusion (12.5 mL/hour) creates 




















Infusion Delay Problem   
Figure 1   Eight-hour Medication Frequency Timeline 
Intended infusion administration:  
 
0hr                               2hr                              4hr                               6hr                     8hr      
 
                    
 
           50% MIC infusion for 4 hours                        No infusion for 4 hours 
           Piperacillin/tazobactam  
           50ml at 12.5ml/hr 
 
Duration problem with current infusion administration: 
 
                                                                                
      
   No medication            Med reaches patient      Period left to  
reaches patient           and begins infusing      nursing judgment 
      for approx. 2hrs         at intended rate               with inconsistent  
   but is documented         actions   
   as infusion time  
 
 
What is the solution?  
There is a potential for significantly impacting patient benefits from extended 
infusions just by adjusting the current administration process.  The solution to the 
practice problem involves redefining the beginning of the antibiotic infusion to get the 
dose to the patient for the duration ordered.  This redefinition follows the same concept as 
administering an intravenous push medication.  The intravenous medication doesn’t reach 
the patient’s intravascular space until the dead space (fluid occupying the tubing) is 
displaced by the medication.  In addition, upon completion of the intravenous push, the 
medication is not completely administered until a post-medication flush displaces the 
residual medication still in the tubing.  This same displacement principle can also be used 
to guide redefining the beginning of the extended antibiotic infusion.   
 
Redefinition Guideline  
A patient’s infusion begins at the patient, not at the drip chamber of the 
medication bag.  A 25 mL medication redefinition bolus will displace the dead space 
volume prior to beginning the antibiotic infusion.  The pump will then need to be set to 
deliver 25 mL less in total volume.  A post-infusion flush will be delivered at the same 
medication infusion rate until the tubing is cleared of medication.  Using this process, 
patients will receive the ordered amount of medication for the ordered duration at the 
time documented in the EPR.  This process is compatible with either continuous infusions 





                                                                                                                                                           
New Procedure:  WITHOUT Continuous IV Fluid  
Infusion Pathway: 
(Backpriming is unnecessary when reusing dedicated tubing since tubing will be 
primed.)   
1. Prime the tubing with 25 mL of medication bolus as directed in Table 1 below.  
[When hanging new tubing, backprime the new secondary tubing with NS before 
spiking the new secondary bag to remove air for priming procedure.] 
2. Set secondary VTBI for 25 mL less than secondary bag volume (to account for 
priming). 
3. Set primary VTBI for 25 mL (to flush infusion tubing following secondary 
infusion).   
Rate must be the same as the secondary medication rate because medication is 
continuing to infuse during this flush.   
4.  The infusion is complete when the smartpump alarm signals completion of the 
primary NS flush, a total duration of 4 hrs of intravascular exposure.  
5.  Disconnect the infusion pathway between extended infusions to enhance patient 
mobility. 
 
New Procedure:  WITH Continuous IV Fluid  
Same above except:  
1. Verify compatibility with continuous fluids 
2. Continuous fluids will be delivered simultaneously using a separate smartpump.   
3. Connect infusion tubing to the continuous IV fluid tubing via the port closest to 
the patient.  
4. Optional to leave medication tubing connected during dormant intervals if 
smartpumps share one pole.                                      
                                                                                                                                                                                                                                                                                                                         
Setting Summary 
Program priming bolus of medication:  
Rate 999 mL/hr with VTBI 25 mL (must occlude primary tubing during bolus) 
 
Set secondary IVPB and Primary flush the same: 


















Medication Bolus Instructions 
Nursing Action Rationale 
Hang the new medication container and open the 
clamp. 
The secondary medication is ready for 
infusion. 
[Backpriming is only needed when hanging new 
secondary tubing.  Do not spike the new 
medication bag during backpriming.] 
[Spike medication bag after backpriming 
new tubing to avoid adding any volume to 
the new medication bag. This maintains 
consistency of the priming bolus at 25 mL 
and reduces the risk of error.] 
Program a secondary IV fluid bolus rate at 999 
mL/hr for a VTBI of only 25 mL. 
This redefines the beginning of the 
infusion as the patient’s intravascular 
space rather than the secondary drip 
chamber) 
Press run to prime the infusion tubing while 
pinching the primary tubing closed 
throughout the priming bolus.  The 25 mL 
priming bolus from the container to the patient 
will take 90 seconds and the smartpump will 
signal completion.   
The rapid bolus rate will otherwise pull the 
bolus from both the primary and secondary 
containers, regardless of the lowered height 
of the primary fluid. The priming bolus 
must be pulled entirely from the IVPB to 
begin the medication infusion at the 
patient’s intravascular space.  
Reprogram the secondary infusion for the 
ordered rate of the four-hour infusion. 
The medication infuses at the rate ordered. 
Reprogram the secondary infusion VTBI for the 
amount in the container minus the 25 mL 
redefinition bolus.   
The medication infusion pathway has 
already been primed with 25 mL of the 
medication, leaving less in the bag. 
The primary fluid flush can be programed at this 
time.  Set the primary fluid flush rate at the same 
rate as the medication ordered for a VTBI of 25 
mL.   
The primary fluid flush clears the residual 
medication from the tubing once the 
secondary container is empty.  Medication 
continues to infuse at the ordered rate 
during this time for up to two more hours.   
Attach the setup to the patient’s access and press 
run to begin the extended infusion.   
The medication infuses at the dosage 
ordered, for the duration ordered, in the 
intravascular space as ordered. 
Documentation indicates accurate infusion begin 
and end times. 
Documentation supports the patient’s 
intravascular space as the beginning of the 
extended infusion. 
The infusion is complete when the smartpump 
alarm signals completion of the primary fluid 
flush after a total duration of four hours.  
The patient has received optimal 
intravascular extended exposure to the 






Frequently Asked Questions & Answers 
1.  Should I do this bolus with all IVPBs?   
No. Other IVPBs infuse faster and reach the patient quickly. It’s the slow rate of the 
extended infusion and the dead space volume (25 mL) that creates the significant 
infusion delay.  
  
2.  Could I just use a primary IV set for the infusion? 
That would deliver the med to the patient but traps significant residual (34%) med 
in the tubing at the end of the infusion.  Repeated disconnections would be needed 
to flush the line.  In addition, the unidirectional valve apparatus in the primary 
tubing differentiates the primary and secondary tubings for the pump.  The 
secondary tubing could not be used as a flush with this system. 
 
3.  What if I forget to occlude the primary line during the bolus? 
You would see drops falling from both the primary and secondary bags meaning 
you were diluting the medication prime of the tubing. Be sure to also limit the 
VTBI to 25 mL! 
 
4.  Why do we prime the line with 25 mL?  
This is the average of the 21-28 mL dead space volume of various tubings, 
extensions, and catheters commonly used for infusion setups.   
 
5.  Why would the IVPB policy not apply to this infusion?  
It is the slow rate creating the two-hour infusion delay for the patient.  Longer 
duration infusions must be managed differently, especially when rates are less than 


























Post Instruction Questions (Circle the correct answer and submit with the attestation 
form.) 
1.  The most significant evidence supporting patient benefits from extended antibiotic 
infusion therapy includes:  
A. Decreased mortality and lengths of stay 
B. Improved would healing and pain control 
C. Reductions in leukocytosis and thrombocytopenia 
D. Enhanced functional capacity and mental status. 
 
2.   Which statement describes the rationale for redefining the beginning of the extended 
antibiotic infusion? 
A. A patient’s infusion begins at the patient, not the secondary drip chamber.  
B. Dead space volume between the secondary container and the patient creates the 
potential for a significant infusion delay. 
C. Time-dependent antibiotics need intravascular exposure time for effective 
bactericidal activity.  
D. All the above are correct. 
 
 3.  In the redefinition process, what must the nurse be doing throughout the 90 second 
bolus? 
A. Monitoring patient response closely for any signs of adverse reaction or 
hypersensitivity 
B. No special intervention is needed during this time. 
C. Pinching the primary tubing closed so the redefinition bolus is only pulled from 
the secondary antibiotic container. 
D. Pinching the secondary antibiotic tubing closed so the redefinition bolus is only 
pulled from the primary container. 
 
4.  What would be the correct order of actions when administering extended antibiotic 
infusions using the improved process? 
A. Bolus, backprime, secondary infusion, primary fluid flush 
B. Backprime, bolus, secondary infusion, primary fluid flush 
C. Primary fluid flush, bolus, backprime, secondary infusion 
D. Secondary fluid flush, primary infusion, bolus, backprime  
 
5.  The redefinition bolus only applies to extended antibiotic infusions because: 
A. Dead space volumes are the same for all IVPB infusions so perhaps it should 
apply to all. 
B. Greater IVPB volumes infusing faster reach the patient much more quickly 
without significant delays.   
C. Small IVPB volumes and slow rates significantly delay the antibiotic from 
reaching the patient. 







Quality Improvement of the Extended Antibiotic Infusion Administration Process:   
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Extended Antibiotic Infusion Redefinition Project Staff Survey  
 
DIRECTIONS:   Please indicate your response to the questions below as follows: 






I found the redefinition instructions easy to understand.                                          1   2   3   4   
 
It took a reasonable amount of time to complete the self-instruction module.         1   2   3   4    
 
My awareness of managing intravenous infusion volume is improved                    1   2   3   4    
following the self-instruction module. 
My awareness of time-dependent antibiotics is improved following the                 1   2   3   4    
self-instruction module. 
Upon completion of the self-instruction module, I feel comfortable                       1   2   3   4    
implementing the redefinition process independently. 
The redefinition process improves extended antibiotic infusion therapy                 1   2   3   4    
for my patients. 
I would recommend a system-wide implementation of the self-instruction             1   2   3   4    
module for nurses. 
Have you administered extended Zosyn since completing the self-instruction module? If so, 































Appendix  SECONDARY SECONDARY PRIMARY PRIMARY 
  DATE RATE VOLUME RATE VOLUME 
       
1   March 28, 2018 12.5 25 12.5 20 
2  March 28, 2018 12.5 25 12.5 20 
3  March 28, 2018 12.5 50 25 50 
4  March 29, 2018 12.5 50 50 100 
5  March 29, 2018 12.5 50 50 42 
6  March 29, 2018 12.5 50 50 100 
7  March 30, 2018 12.5 25 12.5 20 
8  March 30, 2018 12.5 25 12.5 20 
9  April 2, 2018 12.5 50 25 50 
10  April 2, 2018 12.5 25 12.5 20 
11  April 3, 2018 12.5 25 12.5 20 
12  April 3, 2018 12.5 50 50 50 
13  April 3, 2018 12.5 50 100 50 
14  April 4, 2018 12.5 25 12.5 50 
15  April 4, 2018 12.5 50 12.5 20 
16  April 4, 2018 12.5 25 12.5 20 
17  April 5, 2018 12.5 50 25 100 
18  April 5, 2018 12.5 25 12.5 20 
19  April 5, 2018 12.5 50 12.5 20 
20  April 5, 2018 12.5 50 50 50 
21  April 7, 2018 12.5 50 50 100 
22  April 10, 2018 12.5 25 12.5 20 
23  April 11, 2018 12.5 50 50 50 
24  April 11, 2018 12.5 50 25 740 
25  April 11, 2018 12.5 25 12.5 20 
26  April 12, 2018 12.5 25 12.5 20 
27  April 17, 2018 12.5 50 12.5 50 
28  April 17, 2018 12.5 25 12.5 20 
29  April 18, 2018 12.5 25 12.5 25 
